About Us
Unique entrepreneurship and hands on approach
Transaction solely executed by senior team
One stop shop advisory practice
For further information about consulting services : Who we are – Bionest
Executive Leadership
Georges-David Medina
Georges-David founded Bionest Partners Finance in 2006 to advise small and medium-sized businesses in the healthcare and healthtech sectors.
He has carried out more than 150 advisory and cross-border transactions involving large corporate groups.
Before BPF, Georges-David was an equity research analyst at Exane, Natexis Bleichroeder and Bryan Garnier where he oversaw Pharma and MedTech coverage.
He is a doctor of pharmacy and a graduate of HEC.
Senior Advisor Leadership
Olivier Ast
Operating Partner Europe
Olivier leverages experiences in corporate strategy and in business development in Big Pharma, strategy consulting firms and biotech start-ups. He had the chance to support the CEO of mid-size pharma to redefine the corporate strategy and to lead a divesting project of R&D assets to a Big Pharma.
He is also a business angel and board member of a biotech (Huntx Pharma).
He studied at Harvard Business School (PLD), Columbia University (M.Sc.) and at Ecole Centrale de Lyon (M.Sc.).
Marco van der Putten Landau
Operating Partner Asia
Marco began his professional career in 2002 in Beijing, gaining over 20 years of experience in entrepreneurial, financial advisory, and educational projects in China through the companies he co-founded, Eyes on China and Hodaya International.
His leadership is strengthened by early exposure to diverse cultures and languages. He is actively involved in the medical and renewable energy sectors and is fluent in multiple Western and Eastern languages.
Rachel Laing
Managing Director Bionest, Basel
Rachel heads the European activities of Bionest, bringing more than ten years of scientific and consulting expertise to Bionest and its clients.
Rachel supports pharma, biotech, and diagnostic companies on strategic assignments encompassing new product planning and go-to-market strategy. She collaborates with her clients to foster creative and innovative thinking, drive cross-functional alignment, and deliver pragmatic and actionable solutions to help grow and develop the business.
Rachel has a specific expertise in and passion for oncology and diagnostics, owing to her scientific background. She leads the Oncology and Precision Medicine practices at Bionest and is a recognized thought leader in the space.
Julius Steffen
Managing Director Bionest, New York
Julius is a Partner in the New York office. Prior to joining Bionest in 2016. Julius worked for 5 years in the healthcare sector, both on the consulting and industry side.
He has extensive experience in the areas of opportunity assessment, organization design, forecasting, resource prioritization and marketing strategy.
Julius has worked on assignments across a broad range of countries in EU, US, Middle East and Africa. He holds an MSc in Economics which he obtained during studies in Berlin, New York and London.
Jean-Baptiste Mayet
Principal, Bionest, Paris
Jean-Baptiste is a Principal in the Paris office. Prior to joining Bionest, Jean-Baptiste worked with Sanofi in business development for emerging markets.
At Bionest, Jean-Baptiste has mainly advised biotech and large pharma on portfolio / TA prioritization, go-to-market strategy (US / EU), market access and pricing strategy as well as launch readiness. Jean Baptiste’s areas of expertise include, among others, gene & cell therapies, oncology, diagnostics, and orphan diseases.
He holds a Pharm. D from Université Paul Sabatier and a Master in Science of Management from EM Lyon Business School.
Alain Gilbert
Pharmaceuticals
Alain co-founded Bionest Partners in 2003 after a 30-year career in the life sciences and healthcare industry.
Over this time, Alain held a.z number of top executive management positions around the globe with pharma and device companies such as Abbott Laboratories and Medtronic.
Alain also led innovative companies at the commercial stage, notably as a European founder of Biogen where he was responsible of the launch of Avonex.
Alain offers an unique combination of experience as a leader and manager of businesses, he also served as board member of many European biotech companies.
Claude Allary
Biotechnology / Vaccines
Claude co-founded Bionest Partners in 2003.
Before joining Bionest Partners, Claude was Vice President at ISO Healthcare (1998-2002) and Senior Consultant at Arthur D. Little (1991-1998).
Claude also held several positions in the industry at Glaxo PLC International, Rhone Poulenc Santé and Park Davis.
Claude is graduated from ESSEC.
Philippe Moreau
Animal Health
Philippe Moreau is founder of Mediproductions, a marketing and communication company dedicated to the veterinary clinic that he developed internationally through new product launches and licensing agreements with leading animal health companies (Idexx, Merial, Virbac).
He is Past President of the NAVC (North American Veterinary Conference) and has given more than 200 lectures and training sessions.
Philippe is a veterinary Doctor and graduated from University of Liège (Belgium) and Purdue University (Texas).